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Cerebral ischemia-reperfusion (I-R) transiently increased autophagy by producing excessively reactive oxygen species (ROS); on
the other hand, activated autophagy would remove ROS-damaged mitochondria and proteins, which led to cell survival.
However, the regulation mechanism of autophagy activity during cerebral I-R is still unclear. In this study, we found that
deficiency of the TRPM2 channel which is a ROS sensor significantly decreased I-R-induced neuronal damage. I-R transiently
increased autophagy activity both in vitro and in vivo. More importantly, TRPM2 deficiency decreased I-R-induced neurological
deficit score and infarct volume. Interestingly, our results indicated that TRPM2 deficiency could further activate AMPK rather
than Beclin1 activity, suggesting that TRPM2 inhibits autophagy by regulating the AMPK/mTOR pathway in I-R. In conclusion,
our study reveals that ROS-activated TRPM2 inhibits autophagy by downregulating the AMPK/mTOR pathway, which results
in neuronal death induced by cerebral I-R, further supporting that TRPM2 might be a potential drug target for cerebral
ischemic injury therapy.
1. Introduction
The balance of reactive oxygen species (ROS) production and
elimination maintains the cellular redox homeostasis, which
is vital to cell survival in various physiological and patholog-
ical conditions [1]. Cerebral ischemia-reperfusion (I-R) is a
clinical disorder characterized by severe neurological dys-
functions, which is a leading cause of long-term disability
and death globally [2]. Due to the drastic interruption of blood
supply, followed by reperfusion, the balance of generation of
excessive ROS and the tissue’s ability to detoxify ROS are dis-
rupted. The I-R injury was found dependent on the reintro-
duction of oxygen, indicating that ROS would possibly be
the main cause of neuronal death in reperfusion injury [3].
ROS overproduction leading to cell death was a complexmode
involving necrosis, autophagy, and apoptosis in I-R injury [4].
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As a ROS sensor, the TRPM2 channel is a Ca2+ perme-
able nonselective cation channel and is activated by the aden-
osine diphosphate-ribose (ADPR) [5] that is generated
through poly(ADPR)polymerase (PARP)/poly(ADPR)glyco-
hydrolase (PARG) pathway [6]. Recent studies have linked
TRPM2 to cerebral I-R injury. For example, TRPM2 defi-
ciency or pharmacological inhibition of TRPM2 prevented
oxygen and glucose deprivation reperfusion- (OGD-R-)
induced neuronal death in cultured mouse cortical neurons
[7, 8]. In addition, the neuronal death of TRPM2 knockout
(TRPM2 KO) mice induced by the transient middle cerebral
artery occlusion (tMCAO) model was substantially attenu-
ated compared to that of WT mice [9]. In addition, previous
studies reported that TRPM2mediated neuronal death in I-R
by resulting in Zn2+ accumulation [10], regulating NMDAR
expression level [11] and inducing inflammation [12]. Since
brain I-R injury is a complex pathological process, it is still
important to explore whether TRPM2 mediated I-R injury
by regulating other critical pathways.
Accumulating evidence has indicated that autophagy
plays a critical role during cerebral I-R injury. For example,
inhibition of autophagy in the reperfusion phase reinforces
I-R injury [13], indicating a protective role that autophagy
plays in cerebral I-R. In contrast, a recent study reported that
Beclin1 deficiency or RNAi knockdown protected the neuro-
nal death in the tMCAO model, suggesting that Beclin1-
dependent autophagy mediated the neuronal damage during
I-R injury [14]. In addition to Beclin1, it has been demon-
strated that hypoxia or ischemia enhances AMP-activated
protein kinase (AMPK) activity [15], which further inhibited
its downstream protein mammalian target of rapamycin
(mTOR) to enhance autophagy [16]. Therefore, modulating
autophagy and its upregulated molecular pathways may be
beneficial for the treatment of ischemic stroke. Interestingly,
recent studies reported that TRPM2 regulates autophagy
[17, 18]. For example, a recent study found that TRPM2
deficiency inhibited H2O2-induced AMPK phosphorylation
in neutrophils, suggesting the regulation of the AMPK sig-
naling pathway by TRPM2 [17]. Besides, a recent study
reported that TRPM2 channel activation mediated calcium
influx, which activated calcium/calmodulin-dependent pro-
tein kinase II (CaMK II) and subsequently phosphorylated
Beclin1 to inhibit autophagy [18]. It will be attractive to
determine whether TRPM2 mediates I-R injury by regulat-
ing autophagy.
In this study, we investigated the role of TRPM2 in
autophagy-dependent cerebral I-R. The underlying rationale
was that I-R-induced oxidative stress activates TRPM2 chan-
nels [19], and TRPM2 activation leads to Ca2+ influx, which
in turn affects autophagy flux [18]. Our results demonstrated
that the ROS-activated TRPM2 channel impairs autophagy
induction by regulating the AMPK/mTOR pathway during
cerebral I-R.
2. Materials and Methods
2.1. Animals. The TRPM2-/- mice were generated in Univer-
sity of Leeds [20] and the mice used in this study were bred in
Zhejiang University. All experiments were approved by and
conducted following the ethical guidelines of the Zhejiang
University Animal Experimentation Committee.
2.2. Antibodies and Reagents. Antibodies against Cathepsin B
(1 : 1000, 21718S), cleaved caspase 3 (1 : 1000, Asp175, #9661),
caspase 3 (1 : 1000, #9662), phosphorylated-AMPK, AMPK
(1 : 1000, 2532S), phosphorylated-mTOR (1 : 1000, #2974),
and mTOR (1 : 1000, #2983) were purchased from Cell Signal-
ing Technology (CST, US). Secondary antibodies (1 : 2000)
conjugated to horseradish peroxidase were purchased from
Santa Cruz Biotechnology. All chemicals were obtained from
Sigma-Aldrich or MedChemExpress unless stated otherwise.
Stock solutions of compounds were prepared in dimethyl-
sulphoxide (DMSO) or water. The stock chemicals were
stored as aliquots at -20°C.
2.3. Preparation of tMCAO Mouse Model. Microsurgery of
tMCAO was conducted on the 8-week-old wild-type
(C57BL/6) or TRPM2 knockout male mice. Mice were anes-
thetized for surgery via inhalation of isoflurane. We utilized
laser Doppler flowmetry (Moor Instruments, Devon, UK)
to monitor the cerebral blood flow (CBF) in the territory of
the middle cerebral artery (MCA). Animals with less than
80% reduction in CBF in the core of the MCA territory were
excluded from the study.
Transient focal cerebral ischemia was induced by MCAO
as described previously [21–23]. Briefly, a 6–0 nylonmonofil-
ament suture was inserted into the internal carotid to occlude
the origin of the MCA. The nylon suture was removed after
1.5 hours to allow reperfusion. Mice were given a tail vein
injection of LY294002 (MCE, HY-10108, 5mg/kg) or intra-
cerebroventricular injection of 7.5μg 3-methyladenine (3-
MA, Sigma, M9281) at the beginning of reperfusion. The same
volume of PBS was given to control mice. After the completion
of microsurgery, mice were transferred to a heated cage (37°C)
for recovery and then transferred to their cages.
2.4. Evaluation of Neurological Deficit Score and Infarct
Volume. Neurological deficit scores were evaluated after
24 h of reperfusion according to the following rule: 0, no def-
icit; 1, failure of extending of contralateral forelimb; 2, cir-
cling to the right side; 3, falling to the contralateral side;
and 4, lacking spontaneous motor activity. After evaluation
of the neurological deficit score, the mice were sacrificed,
and brain tissue was dissected. After storing at -20°C for 30
minutes, infarct volumes were stained with 2,3,5-triphenyl-
tetrazolium hydrochloride (TTC; 0.25%; Sigma, T8877) and
fixed in 4% paraformaldehyde overnight. Finally, the infarct
areas were measured with the ImageJ software (National
Institutes of Health) and determined by a researcher blinded
to the experiments.
2.5. Viral Injection. Five-week-old mice were prepared for
stereotaxic injection. The detailed protocols have been
described previously [24] with minor modifications. Briefly,
animals were placed into the anesthesia induction chamber
with 2.5% isoflurane and then immobilized on a stereotaxic
apparatus. A volume of GFP-mRFP-LC3-AAV virus solu-
tion was injected into the bilateral cortex region (1μl,
bregma = 0:20mm; lateral ± 3:20mm; ventral 1.50mm) using
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a microinjector with a glass electrode at a rate of 0.1μl min−1
with an infusion pump. The syringe needle was left in place
for 10min and withdrawn, and the injection repeated in the
opposite hemisphere and then suturing the skin of the head
by applying iodophor for disinfection. The mice were placed
in a clean cage and with access to water and food ad lib for 3
weeks until the virus expressed for tMCAO. Three weeks later,
the tMCAO was performed on these mice. Animals that had
undergone tMCAO microsurgery were deeply anesthetized
with pentobarbital (100mgkg–1, i.p.) and perfused transcra-
nial with saline followed by 4% PFA in 0.1M PBS, pH7.4.
Brains were removed, postfixed overnight in 4% PFA at 4°C
and transferred to 30% sucrose in 0.1M PBS, pH7.4. Coronal
sections (50μm) were cut on a cryostat (Leica CM3050 S,
Leica Biosystems, IL, USA) and stored in 0.1M PBS. Sections
were then mounted on DAPI-Fluoromount-G overnight. The
images were taken using a LSM880 inverted confocal micro-
scope fitted with a ×63 oil objective (LSM880, Carl Zeiss,
Jena, Germany) and appropriate excitation (GFP, 494nm;
mRFP, 548nm) and emission (GFP, 519nm; mRFP, 562nm)
wavelengths.
2.6. Primary Cortical Neuronal Cell Culture and OGD
Reperfusion Procedures. The dissected cortex from embry-
onic day 17 fetal mice were digested with 0.25% trypsin (Invi-
trogen; 25200-056) for 8 minutes. Then, Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 20% fetal
bovine serum (FBS) was added to inactivate trypsin. The cell
suspension was obtained with triturating 2-3 times with the
above medium. Approximately 105 cells/cm2 were seeded
onto poly-D-lysine (Sigma; P7405)-coated glass-bottom
dishes (Cellvis; D29-20-1-N) for live cell imaging. ForWestern
blot, cells were seeded and cultured in cell culture dishes
(Corning). Neurons were grown in Neurobasal medium
(Gibco; 21103049) supplemented with 2% B27 Supplement
(Gibco; 17504044) and 0.25% GlutaMAX Supplement (Gibco;
35050-061). Cultures were maintained for 8–11 days before
treatment.
For OGD treatment, DIV8–11 primary cultured neurons
were refreshed with glucose-free DMEM (Gibco; 11966025).
Cells were then immediately placed in Hypoxia Incubator
Chamber (Stemcell; 27310) loaded with mixed gas contain-
ing 5% CO2 and 95% N2 as indicated. For reperfusion, neu-
rons were refreshed with the normal culture medium.
2.7. SH-SY5Y Cell Culture and OGD Reperfusion Procedures.
The SH-SY5Y cell lines were seeded onto poly-D-lysine
(Sigma; P7405)-coated glass-bottom dishes (Cellvis; D29-20-
1-N) for live cell imaging. Cells were grown in DMEM/F12
(Gibco; 11320033) supplemented with 10% FBS (PAN;
ST30-3302).
For OGD treatment, cultured cells were refreshed with
glucose-free DMEM (Gibco; 11966025). Cells were then
immediately placed in Hypoxia Incubator Chamber (Stem-
cell; 27310) loaded with mixed gas containing 5% CO2 and
95% N2 for 6 hours. Cells were refreshed with normal culture
medium during the reperfusion stage for 6 hours. For live cell
autophagy flux experiments, cells were simultaneously incu-
bated with N-(p-amylcinnamoyl) anthranilic acid (ACA,
MCE, HY-118628), Torin 1 (MCE, HY-13003), or N-acetyl
cysteine (NAC, Sigma, A7250) at its working concentration


































































Figure 1: Time-lapse of ROS production under OGD-R treatment. (a) Primary cortical neurons treated with medium alone (CTRL) or 1 h of
OGD plus different time (1 h, 2 h, or 3 h) of reperfusion (OGD-R) minus or plus NAC (5mM) were stained with H2DCF-DA and subjected to
FACS (number of cells ≥ 2000). (b)Mean ± SEM data from 2 independent experiments. Each experiment performed 2-3 biological replicates.
∗∗p < 0:01; ∗∗∗∗p < 0:0001; one-way ANOVA with post hoc Tukey test.
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2.8. Transient Transfection. Primary cortical neurons were
transfected with Mouse Neuron Nucleofector Kit (VPG-
1001, Lonza, Basel, Switzerland) according to the manufac-
turer’s protocol. Briefly, 1 × 106 cells were collected during
primary neuronal culture and then resuspended with 100μL
Nucleofector Solution containing 4μg DNA. The cell suspen-
sion was transferred into the cuvette and electroporated with
Nucleofector Program O-005. Approximately 50% of neurons
can be transfected.
2.9. Cytosolic ROS Measurements in Primary Cortical
Neurons. Cytosolic ROS production was measured by using
cell-permeant 2′,7′-dichlorodihydrofluorescein diacetate
(H2DCF-DA) (Biotium). Upon cleavage of the acetate
groups by intracellular esterase and oxidation, the nonfluo-
rescent H2DCF-DA is converted to the highly fluorescent
DCF. Briefly, cells were treated with various agents for the
desired length of time and then incubated with HBSS
(GIBCO®) containing 10μM H2DCF-DA for 30 minutes at
37°C/5% CO2. Cells (>5000) were collected using ACCU
TASE™ (STEMCELL™), washed, and resuspended in PBS
prior to analysis using a ACEA NovoCyte™ flow cytometer
(Agilent Technologies, No. 205, Zhaohui Road, Hangzhou,
Zhejiang, China). Cytometer settings were optimized for
green (FITC-H) fluorescence, and data were analyzed with
the NovoExpress 1.4.1 Software (Agilent Technologies, No.
205, Zhaohui Road, Hangzhou, Zhejiang, China).
2.10. Electron Microscopy. The primary cortical neurons sub-
jected with OGD reperfusion were fixed by 2.5% glutaralde-
hyde in 0.1M cacodylate buffer. After rinsing in 0.1M
phosphate buffer (pH7.3), the samples were postfixed in
ferrocyanide-reduced osmium tetroxide. These sections were
examined in a FEI Tecnai Spirit (T12) transmission electron
microscope with a Gatan US4000 4k × 4k CCD at the
Zhejiang University EM core facility.
2.11. Live-Cell Imaging of Autophagy Influx. Following the
desired treatments, cells were imaged at 37°C using a
LSM880 inverted confocal microscope fitted with a ×63 oil
objective at appropriate excitation (GFP, 488nm; mCherry,
548 nm) and emission (GFP, 519nm; mCherry, 562 nm)
wavelengths.
2.12. Cathepsin B Activity Assay. Cathepsin B activity was
examined by Cathepsin B Assay Kit (Magic Red) (ab270772,
Abcam) according to the manufacturer’s protocol. Briefly, fol-
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Figure 2: I-R induced neuronal death, which could be rescued by TRPM2 deficiency. (a) Primary cultured cortical neurons were subjected to
1 h of OGD followed by 3 or 6 h of reperfusion (OGD-R 3 h and OGD-R 6 h) at DIV9. The cleaved Casp3, Casp3, and actin levels in cultured
neurons were determined byWestern blot. (b) Semiquantitative analysis showed the ratio of the cleaved Casp3 and Casp3 band intensities. (c)
Mice were subjected to middle cerebral artery occlusion for 1.5 h, and reperfusion was allowed by removing the monofilament suture.
Animals were euthanized 24 h after tMCAO, and representative TTC-stained brain slices from each group are shown. (d) Infarct volumes
were determined by TTC staining in the bar charts (mean ± SD, n = 6). The neurological deficit scores of each group are presented. Data
was quantified from 3–4 independent experiments. ∗p < 0:05; ∗∗p < 0:01; ∗∗∗p < 0:001; ne-way ANOVA with post hoc Tukey test.
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substrate and incubated for 60min at 37°C protected from
light.
2.13. Western Blot. Proteins in the lysates of the cortex were
separated on 10% SDS-PAGE and subjected to Western blot-
ting using corresponding primary antibodies and HRP-
conjugated secondary antibodies. Bands were detected by
chemiluminescence and quantified using Image J.
2.14. Data Analysis. Colocalization between mRFP-LC3 and
GFP-LC3 was analyzed using the Imaris software (Bitplane).
All experiments were performed at least three times (n), and
the values are presented asmean ± SEM or SD. Statistical sig-
nificance was determined using the Student t-test or one-way
ANOVA, followed by Tukey’s post hoc test. Probability (p)
values are indicated with ∗, ∗∗, ∗∗∗, and ∗∗∗∗, which corre-
spond to values of 0.05, 0.01, 0.001, and 0.0001, respectively.
3. Results
3.1. ROS Level Has Been Accumulated in I-R Injury, while
TRPM2 Deficiency Protected Neurons from I-R Injury. ROS
overproduction has been proposed as the main cause of
reperfusion injury, which could further lead to necrosis,
autophagy, apoptosis, and necroptosis resulting in organ
remodeling [3]. Therefore, firstly, we examined the ROS
production during OGD-R treatment. We found that the
ROS level had a modest increase since 1 h of reperfusion
which was reduced by ROS scavenger N-acetyl-L-cysteine
(NAC). Interestingly, the ROS production was significantly
induced at 2 h of reperfusion while followed by a slight
decrease at 3 h of reperfusion (Figure 1). Besides, we found
that the caspase 3 activation was significantly enhanced
with OGD-R time at 3 hours and 6 hours (Figures 2(a)
and 2(b)). These results indicated that significant neuronal
apoptosis and ROS overproduction were caused by I-R
injury. Previous studies reported that TRPM2-KO mice
protected neurons from I-R injury [10]. To verify this,
we also performed the tMCAO experiment and confirmed
that TRPM2 deficiency significantly reduced I-R-induced
infarct volume and neurological deficit score (Figures 2(c)
and 2(d)). Since the mechanism by which TRPM2 defi-
ciency protects neurons from I-R injury remains unclear,
we further explored the mechanism by which ROS-
activated TRPM2 ion channel mediated neuronal death
in I-R.
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Figure 3: Inhibition of autophagy abolishes the protection of TRPM2 deficiency in I-R injury. Mice were subjected to middle cerebral artery
occlusion for 1.5 h, and reperfusion was allowed for 24 h with (a) LY294002 (5mg/kg) or (c) 3-MA (7.5μg) by removing the monofilament
suture. Animals were euthanized 24 h after tMCAO, and representative TTC-stained brain slices from each group are shown. Infarct volume
and neurological deficit score were presented in the bar charts with treatment of (b) LY294002 or (d) 3MA (mean ± SD, n = 6). Unpaired
Student’s t-test.
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3.2. TRPM2 Deficiency Protected Neurons from I-R Injury in a
Promoting Autophagy Induction Manner In Vitro and In
Vivo. Previous studies have shown that autophagy activity
plays a critical role in I-R injury, but which mechanism is still
debatable [13]. Since the TRPM2 channel is activated by ROS
and ADPR [25], and several studies have suggested TRPM2
can regulate autophagy [26, 27], we first tested whether
TRPM2 was involved in autophagy-dependent I-R injury.
As expected, TRPM2 deficiency mice strongly reduced the
infarct volume and improved neurological deficit score in
the tMCAOmodel, which can be abolished by two autophagy
inhibitors, LY294002 and 3-MA (Figure 3). Inhibition of
autophagy in the tMCAO wild-type mice per se seemed not
to alter the infarct volume and neurological deficit score.
These data indicated that TRPM2 deficiency protected neu-
rons from I-R injury by increased autophagy activity.
To further explore how TRPM2 deficiency rescued neu-
ron death through upregulating autophagy, autophagosome
was visualized by electronic microscopy. The autophagosome




































































Figure 4: TRPM2 deficiency promotes autophagy induction under OGD-R in primary cortical neurons. (a) Primary cultured neurons from
WT and TRPM2 KO mice were subjected to 2 h of OGD plus 1 or 3 h of reperfusion in DIV9. Autophagosome was observed by electron
microscopy. Autophagosome was labelled as A and nucleus as N. (b) Primary cultured neurons transfected with mRFP-GFP-LC3 were
subjected to 1.5 h of OGD plus 1 or 3 h of reperfusion (OGD-R 1 h and OGD-R 3 h) in DIV9. Representative z-stack confocal images
showing the colocalization of mRFP-LC3 with GFP-LC3 induced by OGD-R. (c) Columns represent number of mRFP-GFP-LC3 puncta
per cell (mean ± SEM). Scale bars: 10μm. Data was quantified from 3–4 independent experiments. ∗∗p < 0:01; one-way ANOVA with post
hoc Tukey test.
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in WT and TRPM2-KO neurons (Figure 4(a)). However,
after 3 hours of reperfusion, the number of autophagosome
was largely increased. Besides, compared to WT neurons,
there were more autophagosomes in TRPM2-KO neurons
(Figure 4(a)). These data indicated that TRPM2 deficiency
enhanced autophagy induction under OGD-R conditions.
To further confirm our findings, we exogenously expressed
the tandem mRFP-GFP-LC3 to monitor autophagic flux
[28] in cultured primary neurons. GFP fluorescence is
quenched upon fusion between autophagosome and lyso-
some due to the low lysosomal pH, whereas the mRFP sig-
nal remains stable at low pH. Therefore, the yellow signal
(merged of mRFP and GFP) indicates the presence of
autophagosome, while the red signal indicates autolyso-
some. Our results showed that OGD-R increased the
autophagosome formation (GFP+/mRFP+) both in WT
and TRPM2-KO neurons in a reperfusion-time-dependent
manner (Figure 4(b)). At reperfusion of 1 hour, there is
no significant difference between WT and TRPM2-KO neu-
rons. However, at 3 hours of reperfusion, there is more
autophagosome (GFP+/mCherry+) in TRPM2-KO neurons
compared to WT neurons (Figures 4(b) and 4(c)), suggest-

























































Figure 5: TRPM2 deficiency promotes autophagy induction during I-R injury in vivo. (a) WT and TRPM2-KO mice were subjected to sham
or MCAO for 1.5 h followed by 1, 3, or 6 h of reperfusion. Then, brain slices were mounted, and confocal images were taken. Representative
images of cells expressing AAV-mRFP-GFP-LC3 of brain slices fromWT and TRPM2-KO mice are shown. (b) Summary graph showing the
quantification of the number for overlapped puncta, as determined by colocalization of all cells from the experiments shown in (a). Columns
represent number of mRFP-GFP-LC3 puncta per cell (mean ± SEM). Scale bars: 5μm. Data was quantified from 3–4 independent
experiments. ∗∗∗p < 0:001; one-way ANOVA with post hoc Tukey test.
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To further observe the dynamic autophagic flux of I-R
injury in vivo, we injected adeno-associated virus (AAV)
expressing mRFP-GFP-LC3 into the cortex of WT and
TRPM2-KO mice. Fluorescent signals of both mRFP and
GFP were detected in the cortical neurons from the sham
and I-R groups (Figure 5(a)). Consistent with the results in vi-
tro, the number of autophagosome (GFP+/mRFP+) in brain
slices was similar between WT and TRPM2-KO mice
(Figure 5(b)) at 1 hour of reperfusion, while at 3 hours and
6 hours of reperfusion, the autophagosome number from
TRPM-KOmice was largely increased compared to that from
WT mice (Figure 5(b)). These data suggested that TRPM2
deficiency reduced I-R injury through autophagy induction
in vitro and in vivo.
3.3. TRPM2 Deficiency-Promoted Autophagy Is Mediated by
the AMPK/mTOR Pathway to Rescue I-R Injury. A previous
study reported that TRPM2 inhibited autophagy through
Ca2+-CAMK2 cascade-phosphorylated Beclin1 in Hela cells
[16]. We examined the phosphorylation level of the Beclin1
Ser295 site and found that this site has no significant
difference between ischemic WT and TRPM2-KO neurons
(Figure S1), suggested that TRPM2 deficiency promoted I-
R-induced autophagy is Beclin1-independent.
In addition, AMPK has been demonstrated to play a cru-
cial role in autophagy induction in mammalian cells. AMPK
could promote autophagy by phosphorylating autophagy-
related proteins, such as mTOR, which induced initial pha-
gophore formation [29]. A previous study has reported that
the AMPK/mTOR pathway mediates OGD-R-induced cell
injury by promoting autophagosome formation [30]. Since
our above data has demonstrated that TRPM2 plays an
inhibitory role in OGD-R-induced autophagy induction, we
are wondering whether TRPM2 affects autophagy by regulat-
ing the AMPK/mTOR pathway. Our biochemical data
revealed that the level of phosphorylated AMPK was signifi-
cantly enhanced by the tMCAO treatment in WT mice
(Figures 6(a) and 6(b)). Moreover, the phosphorylated
AMPK was further upregulated in TRPM-KO mice com-
pared to WT mice (Figures 6(a) and 6(b)), which indicated
that TRPM2 activated by I-R injury inhibited the AMPK
activation. In contrast, the level of phosphorylated mTOR
was reduced in TRPM2-KO mice compared to that in WT

















































































Figure 6: TRPM2 deficiency-promoted autophagy is mediated by the AMPK/mTOR pathway in I-R injury. (a) WT and TRPM2-KO mice
were subjected to sham or MCAO for 1.5 h, and reperfusion was allowed for 6 h by removing the monofilament suture. Then, the mice were
euthanized, and ischemic penumbra was collected for immunoblot. 3 μg of protein was sequentially immunoblotted with antibodies against
AMPK, phosphorylated-AMPK (p-AMPK), mTOR and phosphorylated-mTOR (p-mTOR), and β-actin. Semiquantitative analysis of (b) p-
AMPK/AMPK and (c) p-mTOR/mTOR is shown. Data was quantified as mean ± SEM from 3-4 independent experiments. ∗p < 0:05; one-
way ANOVA with post hoc Tukey test.
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supporting the activation of AMPK activity in TRPM2 defi-
ciency mice after I-R injury.
Finally, to further confirm ROS/TRPM2/mTOR path-
way negatively contributed to the autophagy activity in I-
R injury, we tracked the autophagy flux by transfecting
mRFP-GFP-LC3 into SH-SY5Y cell. Diffused distribution
of LC3 at a basal level, but OGD-R treatment increased
autolysosome formation (Figure 7(a)). Interestingly, in the
presence of ACA or A10 (Figure S2), two TRPM2 inhibitors,
the autolysosomes were further elevated under OGD-R
(Figure 7). Consistently, NAC, a synthetic precursor of
glutathione (GSH) to eliminate ROS, dramatically raised the
autophagy flux (Figure 7). Moreover, Torin 1, an mTOR
inhibitor, also increased the autolysosome level under OGD-
R condition (Figure 7). Taken together, the AMPK/mTOR
pathway is responsible for TRPM2-mediated autophagy
induction in I-R injury.
4. Discussion
In this study, we identified a novel signaling pathway by
which TRPM2 mediated I-R injury. Our results demon-
strated that OGD-R induced ROS accumulation concomi-
tantly neuronal death, while TRPM2 deficiency attenuated
OGD-R-induced neuronal death and I-R injury. Further-
more, TRPM2 deficiency reduced infarct volume and
increased neurological deficit score in the tMCAO model,





















































Figure 7: Inhibition of TRPM2 or mTOR enhanced autophagy induction in I-R injury. (a) SH-SY5Y cells overexpressing mRFP-GFP-LC3
were treated with OGD for 6 h and then reperfusion for 6 h with normal medium. 30 μMACA, 5mMNAC, or 1 μMTorin1 was added during
reperfusion. Scale bar: 5 μm. (b) The average numbers of red LC3 puncta per cell in each condition were quantified. All data are represented as
mean ± SEM from three independent experiments. ∗p < 0:05, ∗∗∗p < 0:001, and ∗∗∗∗p < 0:0001; one-way ANOVA with post hoc Tukey test.
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inhibition of autophagy by 3-MA or LY-294002 abolished
the protective effect of TRPM2 deficiency in I-R injury. Fur-
ther investigation demonstrated that TRPM2 deficiency pro-
moted autophagy induction both in vitro and in vivo, and this
process was mediated by the AMPK/mTOR pathway rather
than Beclin1. Our results firstly identified that TRPM2 might
impair autophagy to mediate I-R injury. This study pointed
towards new therapeutic opportunities for the treatment of
cerebral ischemia.
Previous studies have reported that autophagy plays a
protective role in I-R injury. Promoting autophagy by uro-
lithin A attenuated renal I-R injury through TFEB-CLEAR
(Coordinated Lysosomal Expression and Regulation) path-
way [31]. Autophagy protected the heart from I-R injury
by attenuating reactive ROS levels and ameliorating mito-
chondrial dysfunction [32]. Our study revealed that
autophagy plays a protective role in TRPM2 deficiency-
mediated cerebral I-R injury. Autophagy is a dynamic
and multistep process that includes phagophore initiation,
autophagosome formation, and fusion with lysosomes for
degradation [33]. Therefore, autophagy can be modulated
at these steps. In the present study, we found that genetic
knockout or chemically inhibition of TRPM2 further upre-
gulates autophagosome formation under I-R in vivo or
OGD-R treatment in vitro. We initially noted that a previ-
ous report demonstrated that TRPM2 activation inhibited
autophagosome initiation by upregulating phosphorylation
of Beclin1 (S295) in Hela cells [18]. Besides, a previous study
found that Beclin1 RNAi has a protective role in cerebral I-R
[14]. Unfortunately, our result showed there is no difference
in phosphorylation of Beclin1 (S295) between WT and
TRPM2 KO mice, indicating that TRPM2 regulated autoph-
agy is independent of Beclin1 in cerebral I-R.
AMPK, a critical energy sensor for energy metabolism,
has been demonstrated to play an important role in autoph-
agy [34, 35]. Under OGD-R treatment or ischemia, the acti-
vation of AMPK in cortical neurons has been reported to
exert neuroprotective effects [36]. To get mechanistic insight
into whether AMPK is involved in TRPM2-mediated
autophagy function, we examined the expression of phos-
phorylated AMPK levels. Consistent with the previous
report, I-R increased phosphorylated AMPK level, and phos-
phorylated AMPK level of TRPM2 deficiency further
increased compared to that of WT mice in cerebral I-R. It
is well known that mTOR can be negatively regulated by
AMPK in autophagy [37]. Accordingly, our results revealed
that TRPM2 deficiency dramatically decreased the phos-
phorylation level of mTOR protein, which is consistent with
the previous study [38]. In addition, our study discovered
that inhibiting mTOR also elevated autophagosome forma-
tion during OGD-R treatment, further supporting the essen-
tial role of mTOR in autophagy. Therefore, we for the first
time demonstrated that TRPM2 activation under I-R
in vivo or OGD-R treatment in vitro impaired autophagy
by downregulating the AMPK/mTOR pathway. However,
the molecular mechanism of the TRPM2 channel regulating
the AMPK/mTOR pathway during I-R is still unclear. Actu-
ally, in the I-R stage, TRPM2-mediated cellular Ca2+ and
Zn2+ increase have been reported; besides, Ca2+ has been
demonstrated to regulate the AMPK/mTOR pathway
[39, 40]. It will be interesting to uncover the relationship
between TRPM2 and AMPK/mTOR signaling pathway
under I-R in the future.
5. Conclusions
In summary, we confirmed that TRPM2 deficiency reduced
ROS-dependent I-R injury and OGD-R-induced neuronal
death. We further uncovered that cerebral I-R injury pro-
duced ROS-activated TRPM2 channel, which inhibited
autophagy induction by attenuating the AMPK/mTOR path-
way rather than Beclin1. Although autophagy is a friend or
foe during cerebral I-R is still debatable, our results indicated
that TRPM2/AMPK/mTOR signaling pathway plays a nega-
tive role in autophagy-dependent cerebral I-R injury. Given
that upregulation of autophagy is considered a useful strategy
to prevent cerebral I-R injury, our findings provide new ther-
apeutic opportunities for ischemic stroke.
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